KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) EPS (Basic) (2016 - 2025)

Teladoc Health's EPS (Basic) history spans 12 years, with the latest figure at -$0.14 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 46.15% year-over-year to -$0.14; the TTM value through Dec 2025 reached -$1.14, up 80.58%, while the annual FY2025 figure was -$1.14, 80.58% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.14 at Teladoc Health, up from -$0.28 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.05 in Q4 2021 and bottomed at -$41.58 in Q1 2022.
  • The 5-year median for EPS (Basic) is -$0.44 (2022), against an average of -$4.78.
  • The largest annual shift saw EPS (Basic) crashed 46760.0% in 2022 before it soared 99.27% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at -$0.05 in 2021, then tumbled by 46760.0% to -$23.43 in 2022, then surged by 99.27% to -$0.17 in 2023, then crashed by 52.94% to -$0.26 in 2024, then skyrocketed by 46.15% to -$0.14 in 2025.
  • Per Business Quant, the three most recent readings for TDOC's EPS (Basic) are -$0.14 (Q4 2025), -$0.28 (Q3 2025), and -$0.19 (Q2 2025).